ARGX
ARGENX SE
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 3/20/2026 | View on SEC |
| 20-F | 3/19/2026 | View on SEC |
| 6-K | 3/19/2026 | View on SEC |
| 6-K | 3/6/2026 | View on SEC |
| 6-K | 2/26/2026 | View on SEC |
| 6-K | 2/26/2026 | View on SEC |
| 6-K | 1/13/2026 | View on SEC |
| 6-K | 1/12/2026 | View on SEC |
| 6-K | 1/5/2026 | View on SEC |
| S-8 | 12/17/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ARGX |
| Company Name | ARGENX SE |
| CIK | 1697862 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | P7 |
| Phone | 32 (9) 310 34 00 |